News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gilead Sciences, Inc. (GILD)’ Kevin Young CBE, Executive Vice President, Commercial Operations, To Retire



1/7/2014 7:07:32 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Kevin Young CBE, Executive Vice President, Commercial Operations, has informed the company of his decision to retire, effective February 4th. Mr. Young will continue to work directly with Gilead’s management team as a senior advisor.

Mr. Young joined Gilead in 2004 to lead the company’s global commercial operations. During his tenure, he oversaw the launch of eight new therapies, including the first single tablet regimen for the treatment of HIV which is now the best-selling brand-named HIV product in the United States and European Union.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES